ArticlePloS one2017

Growth hormone prescribing and initial BMI SDS: Increased biochemical adverse effects and costs in obese children without additional gain in height.

Daniel B Hawcutt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.